Cardiorenal disease in type 2 diabetes: a paradigm shift in management

Seminar • AstraZeneca

About the CPD course

A thorough presentation developed for UK-based endocrinologists; diabetologists and diabetes-specialist nurses; highlighting the paradigm shift to cardiorenal management in type 2 diabetes mellitus (T2DM). This presentation focuses on clinical outcomes T2DM; heart failure with reduced and preserved ejection fraction, and chronic kidney disease for NICE recommended therapies and key information key information regarding implementation to support healthcare professionals in daily practice to improve patient outcomes.

CPD Provider

AstraZeneca

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.